The class of RBM3 Activators refers to chemical compounds that indirectly modulate the function of RBM3, a protein involved in multiple cellular processes including stress responses. The activity of RBM3 is regulated by the cAMP pathway, so chemicals that influence this pathway indirectly modulate RBM3. This can be achieved by increasing intracellular cAMP levels, a common strategy employed by many compounds in this class. RBM3 (RNA-binding motif protein 3) is a protein that is part of the glycine-rich RNA-binding protein family, which is known to play roles in various aspects of RNA processing and metabolism. RBM3 is involved in processes such as RNA splicing, ribosome biogenesis, and the regulation of gene expression at the level of RNA translation during stress responses, particularly cold stress. As an RNA-binding protein, RBM3 recognizes and binds to specific RNA sequences, influencing the stability and translation of these RNA molecules.
Activators of RBM3 are compounds that enhance the function of this protein, either by increasing its expression levels, stabilizing the protein, or promoting its RNA-binding activity. Direct activators can bind to RBM3 and induce conformational changes that enhance its ability to interact with RNA. This can result in more effective stabilization of target mRNAs or augmentation of the translation process. Such activators might also mimic the natural ligands of RBM3, competing with or displacing them to alter the activity of the protein. Indirect activators can work by influencing the cellular pathways that regulate the expression of RBM3. For example, they might stimulate transcription factors that enhance the transcription of the RBM3 gene or they could inhibit negative regulatory pathways, leading to increased protein synthesis. Other indirect mechanisms might involve the modification of RBM3 post-translational modifications, such as phosphorylation, methylation, or acetylation, which can impact the protein's localization, stability, and interaction with RNA.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylyl cyclase, a key enzyme in the cAMP pathway. By increasing cAMP levels, it indirectly influences RBM3, since RBM3's expression is regulated by the cAMP pathway. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a β-adrenergic receptor agonist. It stimulates the production of cAMP, indirectly modulating RBM3, due to cAMP's role in the regulation of RBM3 expression. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterase, which breaks down cAMP. Increasing cellular cAMP levels indirectly modulates RBM3 due to the role of cAMP in regulating RBM3 expression. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4). By increasing intracellular cAMP levels, it indirectly modulates RBM3, as RBM3 expression is regulated by cAMP. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Vinpocetine is a PDE1 inhibitor. By increasing cAMP levels, it indirectly modulates RBM3, given the role of cAMP in regulating RBM3 expression. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is a selective inhibitor of PDE5. By increasing cAMP levels, it indirectly influences RBM3, given the role of cAMP in regulating RBM3 expression. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline is a non-selective PDE inhibitor and adenosine receptor antagonist. By increasing cAMP levels and blocking adenosine receptors, it indirectly modulates RBM3. | ||||||
Papaverine | 58-74-2 | sc-279951 sc-279951A sc-279951B | 10 mg 50 mg 100 mg | $153.00 $265.00 $459.00 | ||
Papaverine is a non-selective PDE inhibitor. By increasing cAMP levels, it indirectly modulates RBM3, given the role of cAMP in regulating RBM3 expression. | ||||||
Ro 20-1724 | 29925-17-5 | sc-200709 sc-200709A sc-200709B | 100 mg 1 g 5 g | $87.00 $426.00 $1574.00 | 17 | |
Ro 20-1724 is a selective inhibitor of PDE4. By increasing cAMP levels, it indirectly modulates RBM3, due to the role of cAMP in regulating RBM3 expression. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone is a selective inhibitor of PDE3. It increases cAMP levels, indirectly influencing RBM3, given the role of cAMP in regulating RBM3 expression. | ||||||